Endothelin-l-induced GLUT4 translocation is mediated via Gαq/11 protein and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes

被引:72
作者
Imamura, T [1 ]
Ishibashi, K [1 ]
Dalle, S [1 ]
Ugi, S [1 ]
Olefsky, JM [1 ]
机构
[1] Univ Calif San Diego, Dept Med 0673, La Jolla, CA 92093 USA
关键词
D O I
10.1074/jbc.274.47.33691
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endothelin-1 (ET-1) can stimulate insulin-responsive glucose transporter (GLUT4) translocation in 3T3-L1 adipocytes (Wu-Wong, J. R., Berg, C. E,, Wang, J,, Chiou, W, J,, and Fissel, B. (1999) J. Biol. Chem. 274, 8103-8110), and in the current study, we have evaluated the signaling pathway leading to this response. First, we inhibited endogenous Ga-q/11 function by single-cell microinjection using anti-G alpha(q/11) antibody or RGS2 protein (a GTPase activating protein for G alpha(q)) followed by immunostaining to quantitate GLUT4 translocation in 3T3-L1 adipocytes, ET-l-stimulated GLUT4 translocation was markedly decreased by 70 or 75% by microinjection of G alpha(q/11) antibody or RGS2 protein, respectively. Pretreatment of cells with the G alpha(i) inhibitor (pertussis toxin) or microinjection of a G beta gamma inhibitor (glutathione S-transferase-beta-adrenergic receptor kinase (GST-BARK)) did not inhibit ET-1-induced GLUT4 translocation, indicating that G alpha(q/11) mediates ET-1 signaling to GLUT4 translocation. Next, we found that ET-l-induced GLUT4 translocation was inhibited by the phosphatidylinositol (PI) 3-kinase inhibitors wortmannin or LY294002, but not by the phospholipase C inhibitor U-73122. ET-1 stimulated the PI 3-kinase activity of the p110 alpha subunit (5.5-fold), and microinjection of anti-p110 alpha or PKC-lambda antibodies inhibited ET-stimulated GLUT4 translocation, Finally, we found that G alpha(q/11) formed immunocomplexes with the type-A endothelin receptor and the 110 alpha subunit of PI 3-kinase and that ET-1 stimulation enhances tyrosine phosphorylation of G alpha(q/11). These results indicate that: 1) ET-1 signaling to GLUT4 translocation is dependent upon G alpha(q/11) and PI 3-kinase; and 2) G alpha(q/11) can transmit signals from the ET, receptor to the p110 alpha subunit of PI 3-kinase, as does insulin, subsequently leading to GLUT4 translocation.
引用
收藏
页码:33691 / 33695
页数:5
相关论文
共 25 条
[1]   G protein beta gamma subunits [J].
Clapham, DE ;
Neer, EJ .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :167-203
[2]   Signal transduction mechanisms mediating the vascular actions of endothelin [J].
Douglas, SA ;
Ohlstein, EH .
JOURNAL OF VASCULAR RESEARCH, 1997, 34 (03) :152-164
[3]   Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance [J].
Egawa, K ;
Sharma, PM ;
Nakashima, N ;
Huang, Y ;
Huver, E ;
Boss, GR ;
Olefsky, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (20) :14306-14314
[4]   RAPID DESENSITIZATION OF NEONATAL RAT-LIVER BETA-ADRENERGIC RECEPTORS - A ROLE FOR BETA-ADRENERGIC-RECEPTOR KINASE [J].
GARCIAHIGUERA, I ;
MAYOR, F .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :937-943
[5]   Ligand-independent GLUT4 translocation induced by guanosine 5′-O-(3-thiotriphosphate) involves tyrosine phosphorylation [J].
Haruta, T ;
Morris, AJ ;
Vollenweider, P ;
Nelson, JG ;
Rose, DW ;
Mueckler, M ;
Olefsky, JM .
ENDOCRINOLOGY, 1998, 139 (01) :358-364
[6]  
HARUTA T, 1995, J BIOL CHEM, V270, P27991
[7]   RGS2/G0S8 is a selective inhibitor of Gqα function [J].
Heximer, SP ;
Watson, N ;
Linder, ME ;
Blumer, KJ ;
Hepler, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) :14389-14393
[8]  
Imamura T, 1999, MOL CELL BIOL, V19, P6765
[9]   Endothelin-l modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells [J].
Jiang, ZY ;
Zhou, QL ;
Chatterjee, A ;
Feener, EP ;
Myers, MG ;
White, MF ;
King, GL .
DIABETES, 1999, 48 (05) :1120-1130
[10]   INCREASED PLASMA ENDOTHELIN IN NIDDM PATIENTS WITH RETINOPATHY [J].
KAWAMURA, M ;
OHGAWARA, H ;
NARUSE, M ;
SUZUKI, N ;
IWASAKI, N ;
NARUSE, K ;
HORI, S ;
DEMURA, H ;
OMORI, Y .
DIABETES CARE, 1992, 15 (10) :1396-1397